Advertisement

Disruptors

London-based artificial intelligence company DeepMind, which is owned by Google's parent company Alphabet, is training its software to fold proteins for drug discovery, reports Bloomberg.

Advertisement

DeepMind, Google's artificial intelligence arm, launched an ethics and society research unit to evaluate its breakthroughs in AI science and application, according to a company blog post.

Advertisement